GENENTA SCIENCE SPA - ADR (GNTA) Stock Overview
NASDAQ:GNTA - US36870W1009 - ADR
GNTA Key Statistics, Chart & Performance
The current stock price of GNTA is 3.5 USD. In the past month the price decreased by -7.89%. In the past year, price decreased by -15.36%.
GNTA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.07 | 375.50B | ||
| AMGN | AMGEN INC | 13.01 | 152.70B | ||
| GILD | GILEAD SCIENCES INC | 14.86 | 142.76B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.38 | 101.56B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.56 | 60.77B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.25B | ||
| ARGX | ARGENX SE - ADR | 80.99 | 45.95B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.89 | 40.63B | ||
| INSM | INSMED INC | N/A | 30.67B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.03B | ||
| NTRA | NATERA INC | N/A | 23.06B | ||
| BIIB | BIOGEN INC | 8.79 | 20.62B |
Related stock screener links
About GNTA
Company Profile
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 13 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.
Company Info
GENENTA SCIENCE SPA - ADR
Via Olgettina 58
Milan MILANO IT
Employees: 13
GENENTA SCIENCE SPA - ADR / GNTA FAQ
What is the stock price of GENENTA SCIENCE SPA - ADR today?
The current stock price of GNTA is 3.5 USD.
What is the ticker symbol for GENENTA SCIENCE SPA - ADR stock?
The exchange symbol of GENENTA SCIENCE SPA - ADR is GNTA and it is listed on the Nasdaq exchange.
On which exchange is GNTA stock listed?
GNTA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GENENTA SCIENCE SPA - ADR stock?
7 analysts have analysed GNTA and the average price target is 21.42 USD. This implies a price increase of 512% is expected in the next year compared to the current price of 3.5. Check the GENENTA SCIENCE SPA - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GENENTA SCIENCE SPA - ADR worth?
GENENTA SCIENCE SPA - ADR (GNTA) has a market capitalization of 64.01M USD. This makes GNTA a Micro Cap stock.
How many employees does GENENTA SCIENCE SPA - ADR have?
GENENTA SCIENCE SPA - ADR (GNTA) currently has 13 employees.
What are the support and resistance levels for GENENTA SCIENCE SPA - ADR (GNTA) stock?
GENENTA SCIENCE SPA - ADR (GNTA) has a support level at 3.28 and a resistance level at 3.66. Check the full technical report for a detailed analysis of GNTA support and resistance levels.
Should I buy GENENTA SCIENCE SPA - ADR (GNTA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GNTA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GNTA, evaluating the profitability, health, valuation and growth aspects
- GENENTA SCIENCE SPA - ADR (GNTA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENENTA SCIENCE SPA - ADR (GNTA) Sales and EPS estimates to see what analysts future expectations are.
- GENENTA SCIENCE SPA - ADR (GNTA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENENTA SCIENCE SPA - ADR (GNTA) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENENTA SCIENCE SPA - ADR (GNTA) Stock Chart to make your own analysis
- GENENTA SCIENCE SPA - ADR (GNTA) Latest news and press-releases to stay up to date.
Does GENENTA SCIENCE SPA - ADR (GNTA) stock pay dividends?
GNTA does not pay a dividend.
What is the Price/Earnings (PE) ratio of GENENTA SCIENCE SPA - ADR (GNTA)?
GENENTA SCIENCE SPA - ADR (GNTA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.57).
What is the Short Interest ratio of GENENTA SCIENCE SPA - ADR (GNTA) stock?
The outstanding short interest for GENENTA SCIENCE SPA - ADR (GNTA) is 0.05% of its float. Check the ownership tab for more information on the GNTA short interest.
GNTA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GNTA. When comparing the yearly performance of all stocks, GNTA is a bad performer in the overall market: 86.92% of all stocks are doing better.
GNTA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GNTA. While GNTA has a great health rating, there are worries on its profitability.
GNTA Financial Highlights
Over the last trailing twelve months GNTA reported a non-GAAP Earnings per Share(EPS) of -0.57. The EPS increased by 23.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -60.12% | ||
| ROE | -71.32% | ||
| Debt/Equity | 0 |
GNTA Forecast & Estimates
7 analysts have analysed GNTA and the average price target is 21.42 USD. This implies a price increase of 512% is expected in the next year compared to the current price of 3.5.